2,2'-azino-di-(3-ethylbenzothiazoline)-6-sulfonic acid

BCL2-like 1 ; Mus musculus







27 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 33787344 Gab1 in livers with persistent hepatocyte apoptosis has an antiapoptotic effect and reduces chronic liver injury, fibrosis, and tumorigenesis. 2021 Jun 1 2
2 34659562 Metformin exerts a synergistic effect with venetoclax by downregulating Mcl-1 protein in acute myeloid leukemia. 2021 1
3 30017199 ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma. 2018 Sep 10 1
4 28319809 ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer. 2017 Apr 1
5 28533436 Metformin Synergizes with BCL-XL/BCL-2 Inhibitor ABT-263 to Induce Apoptosis Specifically in p53-Defective Cancer Cells. 2017 Sep 2
6 29237758 Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis. 2017 Dec 13 1
7 27560714 MCL-1 is required throughout B-cell development and its loss sensitizes specific B-cell subsets to inhibition of BCL-2 or BCL-XL. 2016 Aug 25 2
8 25862283 Bcl-xL stimulates Bax relocation to mitochondria and primes cells to ABT-737. 2015 Jul 3
9 25880088 BCL-2 is dispensable for thrombopoiesis and platelet survival. 2015 Apr 16 1
10 26038117 Activation of the Mitochondrial Apoptotic Pathway Produces Reactive Oxygen Species and Oxidative Damage in Hepatocytes That Contribute to Liver Tumorigenesis. 2015 Aug 1
11 24632563 Platelet production proceeds independently of the intrinsic and extrinsic apoptosis pathways. 2014 Mar 17 1
12 25023286 Bcl-xL protein protects from C/EBP homologous protein (CHOP)-dependent apoptosis during plasma cell differentiation. 2014 Aug 22 1
13 25208888 A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis. 2014 Oct 23 1
14 25368242 BH3 mimetics inhibit growth of chondrosarcoma--a novel targeted-therapy for candidate models. 2014 Nov 2
15 22814621 Prophylactic treatment with the BH3 mimetic ABT-737 impedes Myc-driven lymphomagenesis in mice. 2013 Jan 1
16 23341542 ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia. 2013 Mar 21 2
17 23986435 The Bcl-2 homology domain 3 (BH3)-only proteins Bim and bid are functionally active and restrained by anti-apoptotic Bcl-2 family proteins in healthy liver. 2013 Oct 18 1
18 24227720 Tonic activation of Bax primes neural progenitors for rapid apoptosis through a mechanism preserved in medulloblastoma. 2013 Nov 13 1
19 21768359 Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737. 2012 Feb 21 1
20 21997189 Pharmacological blockade of Bcl-2, Bcl-x(L) and Bcl-w by the BH3 mimetic ABT-737 has only minor impact on tumour development in p53-deficient mice. 2012 Apr 1
21 22510411 A defect in cell death of macrophages is a conserved feature of nonobese diabetic mouse. 2012 Apr 27 1
22 22790873 Mcl-1 and Bcl-xL regulate Bak/Bax-dependent apoptosis of the megakaryocytic lineage at multistages. 2012 Nov 1
23 21719460 Evaluation of the Bcl-2 family antagonist ABT-737 in collagen-induced arthritis. 2011 Oct 1
24 20535152 Effective targeting of STAT5-mediated survival in myeloproliferative neoplasms using ABT-737 combined with rapamycin. 2010 Aug 1
25 18841882 Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins. 2008 Nov 13 1
26 19004807 In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas. 2008 Nov 18 1
27 17508927 Small molecule inhibition of the Bcl-X(L)-BH3 protein-protein interaction: proof-of-concept of an in vivo chemopotentiator ABT-737. 2007 1